PDB ID 1PI1     CHAIN A
Protein name Mob1A
Uniprot Accession Q9H8S9
The number of similar proteins 24
The number of binding states 10
The number of binding partners 4

Coloring

Unicolor (beige)

The number of binding partners

Group

Downdload

Format:

Molecule viewer


Only interaction residues
#binding
partners
  4
  3
  2
  1
  0

Sequence information

1   MEATLGSGNL   RQAVMLPEGE   DLNEWIAVNT   VDFFNQINML   YGTITEFCTE   50
51   ASCPVMSAGP   RYEYHWADGT   NIKKPIKCSA   PKYIDYLMTW   VQDQLDDETL   100
101   FPSKIGVPFP   KNFMSVAKTI   LKRLFRVYAH   IYHQHFDSVM   QLQEEAHLNT   150
151   SFKHFIFFVQ   EFNLIDRREL   APLQELIEKL   GSKDR     200

Variants

Residue AA Source dbSNP Clinical
Significance
Allele
Frequency
(> 0.0001)
Disease name
29_GLY ARG 8.3kJPN
chr4:71824724
rs762212825
- 0.0001 -
29_GLY ALA 8.3kJPN
chr4:71824725
-
- 0.0001 -
31_ASP ASN gnomAD
chr4:71824730
rs200143951
- 0.000203074 -
31_ASP VAL 8.3kJPN
chr4:71824731
rs1264404395
- 0.0002 -
53_THR SER 8.3kJPN
chr4:71835687
rs1485546616
- 0.0005 -
54_ILE VAL 8.3kJPN
chr2:74394193
rs1558835307
- 0.0001 -
59_THR ILE gnomAD
chr2:74394177
rs763181628
- 0.000268925 -
86_ILE VAL 8.3kJPN
chr2:74392435
rs954568506
- 0.0001 -
92_LYS GLU 8.3kJPN
chr2:74392417
rs1296209018
- 0.0001 -
94_ILE THR 8.3kJPN
chr2:74392410
-
- 0.0001 -
98_MET VAL 8.3kJPN
chr4:71840949
-
- 0.0001 -
99_THR ALA 8.3kJPN
chr4:71840952
rs779615480
- 0.0007 -
111_PHE CYS 8.3kJPN
chr2:74392359
-
- 0.0001 -
116_GLY SER 8.3kJPN
chr2:74392345
-
- 0.0001 -
143_HIS ARG 8.3kJPN
chr2:74386300
-
- 0.0001 -
144_GLN GLU 8.3kJPN
chr2:74386298
-
- 0.0001 -
154_GLU TER 8.3kJPN
chr4:71844958
-
- 0.0001 -
177_ARG LYS 8.3kJPN
chr4:71847716
rs187615532
- 0.0007 -
192_SER THR 8.3kJPN
chr4:71847760
rs780744296
- 0.0005 -
(Powered by wupsivus)

Reference

PiSite: a database of protein interaction sites using multiple binding states in the PDB, Miho Higurashi, Takashi Ishida and Kengo Kinoshita, Nucleic Acids Research 2009 37(Database issue):D360-D364

COPYRIGHTc2008-2019 Miho Higurashi, Takashi Ishida and Kengo Kinoshita. All rights reserved.